For those that are looking for a “quick Fix” when it pertains to weight loss please beware. A weight loss drug called Belviq may carry increased cancer risk warns the FDA.
Federal regulators are alerting the public that the prescription weight-loss drug Belviq may be associated with an increased risk of cancer, though it’s unclear how big of a risk that might be.
The Food and Drug Administration published the alert Tuesday afternoon, saying that a clinical trial assessing the medication’s safety showed a “possible increased risk of cancer.” Belviq is also known in its generic form as lorcaserin.
“The cause of the cancer is uncertain, and we cannot conclude that lorcaserin contributes to the cancer risk,” the alert said. “However, we wanted to make the public aware of this potential risk. We are continuing to evaluate the clinical trial results and will communicate our final conclusions and recommendations when we have completed our review.”
Unfortunately in efforts to compete in the multi-billion dollar race of products for weight loss and health products, drug companies are producing questionable drugs that might harm the consumer that wants to get a kick start on their weight loss program.
And wouldn’t you know it, The FDA approved Belviq in 2012 as a prescription drug to help overweight and obese adults lose weight. It works by making people feel full.
How in the world does the FDA procedure for approving drugs works? 1. First approve the drug 2. then see how many people are dying, maimed or incapacitated. 3. then go oops, its 2020 now eight years after we approved this drug and everyone is dying, we better switch it to the unapproved list!
©Copyright – Hector Sectzer